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A 1-to-2 Demultiplexer Hybrid Nanocarrier for Cargo Delivery and 
Activation   
Beatriz de Luis,a,b Alba García-Fernández,a,b,c Antoni Llopis-Lorente,a,b Reynaldo Villalonga,e Félix 
Sancenón,a,b and Ramón Martínez-Máñez*a,b,c,d 
A biocomputing strategy implemented in hybrid nanocarriers for 
controlled cargo delivery is described. The nanodevice consists of 
enzyme-functionalized Janus Au-mesoporous silica nanoparticles 
which behaves as an electronic demultiplexer (DEMUX). The 
nanocarrier is capable of reading molecular information from the 
environment (lactose) and selecting one of two possible outputs 
(galactose production or 4-methylumbellilferone release and 
activation) depending on the presence of an addressing input 
(NAD+). 
 The research in the field of nanobotics is a current topic in 
science since they offer promising tools in a great number of 
different areas including diagnostics and therapeutic 
strategies.1 Futuristic nanobots are expected to have specific 
functionalities such as (i) being able to read information from 
the environment, (ii) having autonomous movement and (iii) 
being able to communicate with other nanobots for instance 
through the interchange of chemical messengers.2 In this 
scenario, an attractive characteristic in nanoparticles is to 
design them so that they are able to sense the environment and 
act accordingly. Although simple controlled release 
nanoparticles already perform this action, since they deliver a 
cargo on-command in the presence of certain stimuli, it is 
desirable in this field to design more advanced nanosystems 
capable of performing complex biocomputing operations.  
Biocomputing science, which studies biocompatible 
reactions utilized for information processing and signal 
transduction into YES/NO decisions, is gaining increasing 
attention.3 This behavior mimics the binary (0,1) format of 
Boolean logic operations in electronics. Up to now, different 
discrete and sequential logic gates based on enzymatic 
reactions, fluorescence or absorption switches and DNA cross-
linking, cleavage or strand displacements among others have 
been developed.4-7 These are capable of logically processing 
multiple input signals into a final YES/NO output. However, few 
of such systems have been implemented in nanodevices for 
controlled-release applications. Moreover, considering the 
environmental complexity at the cellular level it is reasonable to 
consider that biocomputing networks of nanodevices with built-
in logics are required to successfully process all the available 
information and achieve a desired final action.  
 With the aim of broadening the scope and exploring the 
implementation of biocomputing operations in stimuli-
responsive delivery applications, herein we report the design 
and preparation of a nanodevice that imitates a 1-to-2 
demultiplexer reading the molecular information from the 
environment and selecting a response. Demultiplexers 
(DEMUX) are digital electronic components used to switch 
signals between different channels in a circuitry.8-11 1-to-2 
demultiplexers process 1 input and select only one of the 
possible 2 outputs depending on the presence or the absence 
of an additional input (addressing input). It can be implemented 
by connecting two AND logic gates operating in parallel and one 
NOT logic gate (Scheme 1A). Previous work from Willner and 
coworkers showcased the realization of a DNA-based 
demultiplexer for the assembly of DNAzyme nanostructures.11 
Here, we have implemented this behaviour by the programmed 
concatenation of enzyme-based reactions implemented in a 
drug delivery nanocarrier conferring the ability to analyze 
potential physiological scenarios and actuate (cargo release) 
only when needed. Besides, taking advance of the efficiency and 
versatility of the enzymes, the whole mechanism is 
complemented with the extra functionality of in situ cargo 
activation once delivered.12 In this way, we expand the utility of 
mesoporous carriers by introducing different biocomputing 
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elements which can be integrated in a complex nanodevice, as 
a versatile strategy for the design of nanosystems with logic 
programmable behaviour. Whereas typical nanocarriers release  
their cargo in the presence of a single stimulus, nanocarriers 
with biocomputing demultiplexer capabilities could be useful 
for the design of more selective delivery systems targeting 
certain cells or tissues where two stimuli are simultaneously 
present. For instance, cancer cells have been demonstrated to 
exhibit elevated levels of both saccharide uptake and 
NAD+/NADH.13,14  
 The nanocarrier (S1enz) is based on Janus Au-mesoporous 
silica nanoparticles which are functionalized with the enzyme 
galactose dehydrogenase (GalDH) on the gold face. The 
mesoporous unit is loaded with a model pro-fluorophore (4-
methylumbelliferyl-β-D-galactopyranoside, MUG) and capped 
with a pH-responsive supramolecular nanovalve consisting of 
an inclusion complex between a benzimidazole derivative and 
β-cyclodextrin (see Scheme S1, ESI). The enzyme β-
galactosidase (β-Gal) attached to the β-cyclodextrin completes 
the design. 
 The operation of the final S1enz nanodevice is depicted in 
Scheme 1B. S1enz is able to sense the presence of lactose (1) 
which is transformed into glucose and galactose by the enzyme 
β-Gal (2). The generated galactose (3) is the “output 1”. 
Moreover, when the enzymatic cofactor NAD+ is also present in 
the environment, the galactose is oxidized to galactono-γ-
lactone by the GalDH enzyme on the Au face. This lactone is 
spontaneously converted to galactonic acid (4) which is the 
“output 2”. When only “output 1” is generated no cargo 
delivery is observed, however, if “output 2” is obtained 
(galactonic acid) a local drop of the pH causes the protonation 
of benzimidazole groups (pKa = 5.55)15 and the dethreading of 
the inclusion complex triggering the delivery of the entrapped 
MUG (5) from the mesoporous face. In addition, an additional 
cargo activation is accomplished by the hydrolysis of the 
glycosidic bond of the released MUG by the β-Gal enzyme 
inducing the appearance of a high fluorescent emission (6) due 
to the formation of 4-methylumbellilferone (MUB). This 
activation step might be crucial in situations where the payload 
needs to be derivatized to overcome solubility and stability 
troubles during the device assembly but reactivated when 
delivered in the target site.16 
 The Janus Au-mesoporous silica nanoarchitecture allowed 
to anchor two different enzymes to the same nanodevice (one 
on the Au face, other on the silica face) using different 
chemistries. In our system, the importance of the selected 
strategy relies on two main factors: (i) there is more space for 
β-Gal immobilization (which is less active than GalDH) on the 
benzimidazole-mesoporous surface; and (ii) GalDH, which is 
commercialized in much lower quantities (as compared to β-
Gal), can be directly immobilized on the Au without the need of 
previous derivatization. Based on enzymatic assays (see ESI), 
the amounts of β-Gal and GalDH on S1enz were determined to 
be 51 and 13 mg per g of nanoparticle, respectively (i.e., 7:3 
Scheme 1. (A) In descending order: representation of a 1-to-2 demultiplexer following electronic symbology and the equivalent switching device, representation of the equivalent 
combinatorial logic circuitry and the corresponding Truth Table that describes the behaviour of the system. (B) Illustration of the nanodevice concatenated three-step enzymatic 
cascade when the input (lactose) and the addressing input (NAD+) are present leading to MUG release and subsequent activation into the strong fluorescent MUB. 
 
Journal Name  COMMUNICATION 
 | 3 
 
 
βGal:GalDH ratio); with lower β-Gal activity (0.007 U·mg-1) as 
compared to GalDH (1.05 U·mg-1). 
 
 
Figure 1. (A) Normalized controlled release kinetic profiles obtained for solid S1enz 
in the absence of stimulus (blank, black curve); in the presence of NAD+ 1 mM 
(pink), in the presence of galactose 1 mM (orange); in the presence of lactose 1 
mM (green) and in the presence of both lactose and NAD+ 1 mM (blue) and 
galactose and NAD+ 1 mM (red). (B) Normalized cargo release from S1enz in the 
presence of NAD+ 1 mM and different saccharides at 1 mM after 4 h.  
 
 After the synthesis and characterization of the nanodevice 
S1enz using standard techniques (see ESI) the 1-to-2 
demultiplexer behaviour was examined. For this purpose, S1enz 
(1 mg·mL-1) was suspended in an aqueous solution at pH 7.5 (20 
mM sodium sulphate) in the absence and in the presence of 
selected stimuli (lactose, galactose, NAD+, galactose + NAD+, 
lactose + NAD+) and the emission of the generated MUB at 445 
nm (λex = 365 nm) was measured. In the absence of stimuli 
(black curve in Figure 1A) a low MUB emission was observed 
(less than 10% of the maximum observed) which is ascribed to 
some remaining not fully capped pores. A negligible MUB 
fluorescence was also observed when S1enz was suspended in 
the presence of only galactose (orange curve), only lactose 
(green curve) and only NAD+ (pink curve), all of them at 1 mM 
concentration. As a clear contrast, a marked MUG 
release/activation from S1enz was observed in the presence of 
the addressing input NAD+ and lactose (both at 1 mM) (Figure 
1A), which is ascribed to the triggering of the whole 
programmed enzymatic pathway as shown in Scheme 2B. 
Moreover, we also observed that when galactose (instead of 
lactose) and NAD+ (1 mM) were used as inputs, MUG release 
and activation are achieved faster (ca. 90% after 60 min) (red 
curve in Figure 1A). This faster response is in agreement with 
the omission of the first step of the enzymatic cascade. In this 
case dethreading of the supramolecular complex and pore 
opening is produced via direct transformation of galactose into 
galactonic acid by GalDH without depending on the previous 
activity of β-Gal. In additional control experiments, S1enz 
response was tested in the presence of other saccharides 
(glucose, fructose and sucrose at 1 mM) and setting the 
addressing input concentration (NAD+) to 1 mM. In all cases 
negligible cargo delivery after 4 h was observed (Figure 1B), 
pointing out the high specificity of the delivery system. 
 The crucial role played by both immobilized enzymes in the 
delivery/activation mechanism was tested using two new 
nanodevices lacking the enzyme GalDH (S1βGal) or the enzyme 
β-Gal (S1GalDH). The MUG delivery/activation process was 
studied with S1βGal and S1GalDH in the presence of both lactose + 
NAD+ at 1 mM concentration after 4 h. It was found that only 
when both enzymes are immobilized on the nanodevice (S1enz) 
the fluorophore MUB is formed, whereas in the case of S1βGal 
and S1GalDH nanoparticles negligible MUG release/activation 
was observed since the cascade enzymatic reactions is not 
complete (Figure 2). Additionally, in order to demonstrate the 
β-galactosidase-mediated activation of MUG into MUB, we 
studied the response of the nanodevice lacking β-galactosidase 
(S1GalDH) by protonation of the benzimidazole subunits dropping 
the pH of the aqueous solution to 4.5. In these conditions, 
negligible MUB fluorescence was observed (Figure S11, ESI) 
since the supramolecular complex between benzimidazole and 
β-cyclodextrin was dethreaded but the released MUG was not 
activated into the highly emissive MUB derivative due to the 
lack of β-galactosidase. However, when β-Gal enzyme was 
added to the suspension, a marked MUB emission was 
observed. Thus, MUG activation is ascribed to the presence of 
β-Gal enzyme and not to changes in environmental chemical 
external conditions such as pH variations. 
Figure 2. Normalized cargo release of different solids with (+) or without (-) 
immobilized enzymes in presence of lactose and NAD+ 1 mM after 4 h of addition. 
  
 Finally, we demonstrated the possible use of this 1-to-2 
demultiplexer at cellular level. First, we assessed the 
biocompatibility of S1enz by cell viability assays which revealed 
that the nanodevice was well-tolerated by HeLa cells at 
concentrations up to 200 μg·mL-1 after 24 h of exposure (Figure 
S12, ESI). In a further experiment, S1enz (75 µg·mL-1) was 
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internalized in HeLa cells and then cells were incubated in the 
absence or the presence of lactose. After 24 hours, MUB 
associated fluorescence was assessed by confocal microscopy 
(Figure 3). Control untreated HeLa cells (Figure 3A) showed 
negligible emission upon excitation at 405 nm while HeLa cells 
incubated with S1enz (Figure 3B) showed a residual background 
signal attributed to cargo delivery from some remaining 
uncapped pores. In contrast, a marked emission was observed 
when HeLa cells were treated with the nanodevice and lactose 
(Figure 3C, see ESI for details). In these conditions S1enz is able 
to transform lactose into galactose and glucose. The galactose 
formed in presence of NAD+ (which is a biomolecule naturally 
available in cells)13 started the enzymatic cascade reactions 
which released MUG and ultimately activated this molecule into 
the highly emissive MUB fluorophore as shown in Scheme 2B. 
Moreover, the fluorescence intensity of the confocal images of 
each treatment was quantified (Figure 3, below) and a 3-fold 
enhancement was observed for HeLa cells treated with S1enz + 
lactose when compared to the cells incubated with the 
nanodevice alone S1enz.  
 
 
Figure 3. Top: controlled cargo release studies of S1enz in HeLa cells. (A) HeLa cells 
without any treatment (B) HeLa cells treated with 75 µg·mL-1 of S1enz and (C) HeLa 
cells treated with 75 µg·mL-1 of S1enz in the presence of lactose 1 mM. Below: ratio 
of mean fluorescence intensity (I/I0) of MUB signal in HeLa cells for both 
treatments (S1enz and S1enz+lactose) (* p < 0.05). 
 
 In conclusion, we report herein the design, synthesis, 
characterization and operation of a new nanodevice (S1enz) 
capable of reading information from the environment and 
processing this information imitating a 1-to-2 demultiplexer. 
Cargo delivery and activation is only observed in the presence 
of both lactose and NAD+, in a process mediated by GalDH and 
β-Gal. The 1-to-2 demultiplexer nanodevice is operative in 
aqueous solution and also when internalized in cells. Although 
we are aware that the illustrated system is a proof of concept, 
it describes a paradigm beyond the simple on-command release 
and activation of a cargo by leveraging organism intrinsic 
biomolecules. We present the use of enzyme-functionalized 
hybrid mesoporous nanodevices as a valuable and versatile 
strategy to tailor different biocomputing elements which may 
be implemented in individual smart nanobots acting according 
to environment information.17 We also envisage the 
interconnection of these nanodevices by means of chemical 
communication18 creating complex networks that operate as 
advanced electronic circuitries performing sophisticated 
executions. In the drug delivery filed, this strategy may open 
unexploited prospects in smart therapies and personalized 
treatments.19 
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